Second Surgery Gets OS Win in Recurrent Ovarian Cancer

(MedPage Today) -- Secondary debulking surgery improved overall survival (OS) for select women with recurrent ovarian cancer in first relapse, an updated analysis from the DESKTOP III trial showed, representing the first phase III trial to demonstrate...